| NO |
Title |
Date |
Submission Obligator |
| 10 |
Material Management Information related to Judgment of Investment(기술이전 계약체결) |
2017/09/12 |
HANALL BIOPHARMA CO.,LTD |
| 9 |
Decision on Disposition of Treasury Stocks |
2017/08/01 |
HANALL BIOPHARMA CO.,LTD |
| 8 |
Implementation and Operation of Compliance Program of the Fair Trade Commission |
2017/08/01 |
HANALL BIOPHARMA CO.,LTD |
| 7 |
Decision on Disposition of Treasury Stocks |
2017/05/29 |
HANALL BIOPHARMA CO.,LTD |
| 6 |
Other Management Information(Voluntary Disclosure) |
2017/04/06 |
HANALL BIOPHARMA CO.,LTD |
| 5 |
Outcome of Annual Shareholders' Meeting |
2017/03/24 |
HANALL BIOPHARMA CO.,LTD |
| 4 |
Decision on Disposition of Treasury Stocks |
2017/03/07 |
HANALL BIOPHARMA CO.,LTD |
| 3 |
[Revised]30% or More Changes in Sales or Profits/Losses (15% or More in the case of Large-scale Corporations) |
2017/03/07 |
HANALL BIOPHARMA CO.,LTD |
| 2 |
Submission of Audit Report |
2017/03/07 |
HANALL BIOPHARMA CO.,LTD |
| 1 |
Decision on Calling Shareholders' Meeting |
2017/03/07 |
HANALL BIOPHARMA CO.,LTD |